CareDx (CDNA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CDNA CareDx

Watchlist

22.600
-0.380-1.65%

Trading Oct 31 14:09 ET

1.19BMarket Cap-7583P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: CareDx to Report Financial Results Post-market on November 04
Moomoo NewsOct 29 21:00 ET
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching With Cutting-Edge Hi-C Technology
BusinesswireOct 23 07:00 ET
H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
Moomoo NewsOct 22 06:31 ET · Ratings
CareDx Showcases Latest Advancements Across Its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
BusinesswireOct 21 07:00 ET
CareDx Analyst Ratings
BenzingaOct 16 09:30 ET · Ratings
CareDx Faces Challenges Amid Disappointing Financial Performance and Overambitious Growth Targets, Warrants Sell Rating by Analyst
TipRanksOct 16 05:55 ET · Ratings

Comments

104159316

Oct 14 09:06

$CareDx (CDNA.US)$ 2 days trade more than 2% good enough for me

Moomoo AI

Feb 14 04:36

Investors may believe CareDx's strong revenue growth is not imminent, leading to a low P/S ratio. Expected future revenue decline could further decrease the P/S ratio, making a significant stock price rise unlikely.

Little Excitement Around CareDx, Inc's (NASDAQ:CDNA) Revenues As Shares Take 28% Pounding

Moomoo AI

Dec 27, 2023 06:12

Despite a strong price move, CareDx's P/S ratio still trails the industry. The low P/S is due to the forecast for sliding revenue. Without significant change, drastic rise in the stock is unlikely.